Patents by Inventor Daniela Mauceri

Daniela Mauceri has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • VEGF-D/VEGFR2/3-mediated regulation of dendrites
    Patent number: 9415090
    Abstract: The present invention relates to methods for modulating, i.e. increasing or decreasing, the length and/or the complexity of the dendrites of a neuronal cell by influencing the amount of vascular endothelial growth factor D (VEGFD)-related signaling. The present invention further relates to methods for treating age- and/or disease-related cognitive dysfunctions, or for impairing the memory of a subject. Finally, the present invention relates to recombinant VEGFD (rVEGFD) for use in the treatment of age- and/or disease-related cognitive dysfunctions.
    Type: Grant
    Filed: June 1, 2012
    Date of Patent: August 16, 2016
    Assignee: Universität Heidelberg
    Inventors: Hilmar Bading, Daniela Mauceri, Christian Klein
  • VEGF-D/VEGFR2/3-Mediated Regulation of Dendrites
    Publication number: 20140093520
    Abstract: The present invention relates to methods for modulating, i.e. increasing or decreasing, the length and/or the complexity of the dendrites of a neuronal cell by influencing the amount of vascular endothelial growth factor D (VEGFD)-related signaling. The present invention further relates to methods for treating age- and/or disease-related cognitive dysfunctions, or for impairing the memory of a subject. Finally, the present invention relates to recombinant VEGFD (rVEGFD) for use in the treatment of age- and/or disease-related cognitive dysfunctions.
    Type: Application
    Filed: June 1, 2012
    Publication date: April 3, 2014
    Applicant: UNIVERSITAT HEIDELBERG
    Inventors: Hilmar Bading, Daniela Mauceri, Chistian Klein
  • VEGF-D/VEGFR2/3-MEDIATED REGULATION OF DENDRITES
    Publication number: 20120308554
    Abstract: The present invention relates to methods for modulating, i.e. increasing or decreasing, the length and/or the complexity of the dendrites of a neuronal cell by influencing the amount of vascular endothelial growth factor D (VEGFD)-related signaling. The present invention further relates to methods for treating age- and/or disease-related cognitive dysfunctions, or for impairing the memory of a subject. Finally, the present invention relates to recombinant VEGFD (rVEGFD) for use in the treatment of age- and/or disease-related cognitive dysfunctions.
    Type: Application
    Filed: June 1, 2011
    Publication date: December 6, 2012
    Applicant: UNIVERSITAT HEIDELBERG
    Inventors: Hilmar Bading, Daniela Mauceri